Skip to content

Author

Jing Li

We have 3 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Preclinical Characterization of [68Ga]Ga/[177Lu]Lu-PSNT-AB: A Dual-Targeted Agent against PSMA and NTSR1 for Prostate Cancer Theranostics.

Prostate-specific membrane antigen (PSMA) is a key biomarker for prostate cancer (PCa), while neurotensin receptor 1 (NTSR1) is positive in PSMA-negative PCa lesions. For comprehensive diagnosis and therapy of PCa, we synthesized dual-targeted PSNT-AB (combining PSMA-targeted EuK, NTSR1-targeted NT-20.3, albumin-bindin...

Quan Xie, Ying Peng, Qing-Zhu Liu et al. · 0 citations
Open access Aug 2026

PCAT6 Regulates IGF2BP1/PD‐L1 to Promote Immune Escape in Breast Cancer

This study aims to elucidate the mechanism through which prostate cancer‐associated transcript 6 (PCAT6) modulates immune escape in triple‐negative breast cancer (TNBC), focusing on its interaction with IGF2BP1 and PD‐L1.

Dingping Sun, Shanglong Sun, Jing Li et al. · 0 citations
Review Open access Sep 2026

Adolescent idiopathic scoliosis non-surgical interventions: a systematic review and network meta-analysis of Cobb angle and SRS-22 outcomes

Some non-surgical interventions may improve Cobb angle in AIS; bracing and Schroth-related therapies show a trend toward relative superiority for short-term Cobb angle control, but results should be interpreted cautiously and not solely based on SUCRA rankings.

Shao-Bo Yang, Fei-Hong Cai, Rui-Xuan Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.